open access

Vol 1, No 3 (2005)
Case report
Published online: 2005-09-17
Get Citation

Orbital pseudotumour in breast cancer patient administered capecitabine therapy. Case report and literature review

Renata Duchnowska, Tomasz Żarnowski
Onkol. Prak. Klin 2005;1(3):165-168.

open access

Vol 1, No 3 (2005)
CASE REPORTS
Published online: 2005-09-17

Abstract

Orbital pseudotumour is a rare chronic and non-specific inflammatory process of unknown etiology. We present here a patient with advanced breast cancer who developed this condition during therapy with capecitabine, an oral fluoropyrimidine derivative. The case is discussed in the context of world literature, with special emphasis on differential diagnosis.

Abstract

Orbital pseudotumour is a rare chronic and non-specific inflammatory process of unknown etiology. We present here a patient with advanced breast cancer who developed this condition during therapy with capecitabine, an oral fluoropyrimidine derivative. The case is discussed in the context of world literature, with special emphasis on differential diagnosis.
Get Citation

Keywords

orbital pseudotumor; capecitabine; paraneoplastic syndrome

About this article
Title

Orbital pseudotumour in breast cancer patient administered capecitabine therapy. Case report and literature review

Journal

Oncology in Clinical Practice

Issue

Vol 1, No 3 (2005)

Article type

Case report

Pages

165-168

Published online

2005-09-17

Bibliographic record

Onkol. Prak. Klin 2005;1(3):165-168.

Keywords

orbital pseudotumor
capecitabine
paraneoplastic syndrome

Authors

Renata Duchnowska
Tomasz Żarnowski

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Wydawcą serwisu jest  "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl